---
title: "Mosapramine - Schizophrenia"
sidebar: mydoc_sidebar
permalink: db13676-mesh-d012559-1.html
toc: false 
---


Path ID: `DB13676_MESH_D012559_1`
{% include image.html url="images/db13676-mesh-d012559-1.png" file="db13676-mesh-d012559-1.png" alt="db13676-mesh-d012559-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C046384">MESH:C046384 </a> | mosapramine | Drug |
| <a href="https://identifiers.org/UniProt:P14416">UniProt:P14416 </a> | Dopamine receptor D2 | Protein |
| <a href="https://identifiers.org/reactome:R-HSA-390651">reactome:R-HSA-390651 </a> | Dopamine pathway | Pathway |
| <a href="https://identifiers.org/MESH:D012559">MESH:D012559 </a> | Schizophrenia | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Mosapramine | DECREASES ACTIVITY OF | Dopamine Receptor D2 |
| Dopamine Receptor D2 | PARTICIPATES IN | Dopamine Pathway |
| Dopamine Pathway | AFFECTS RISK FOR | Schizophrenia |
|---------|-----------|---------|

Reference:
  - [https://go.drugbank.com/drugs/DB13676#mechanism-of-action](https://go.drugbank.com/drugs/DB13676#mechanism-of-action){:target="_blank"}